关注
Chloe Robins
Chloe Robins
在 emory.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Plasma proteomic associations with genetics and health in the UK Biobank
BB Sun, J Chiou, M Traylor, C Benner, YH Hsu, TG Richardson, ...
Nature 622 (7982), 329-338, 2023
4602023
Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis
AP Wingo, Y Liu, ES Gerasimov, J Gockley, BA Logsdon, DM Duong, ...
Nature genetics 53 (2), 143-146, 2021
2702021
Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants
BB Sun, J Chiou, M Traylor, C Benner, YH Hsu, TG Richardson, ...
BioRxiv, 2022.06. 17.496443, 2022
1012022
Genetic control of the human brain proteome
C Robins, Y Liu, W Fan, DM Duong, J Meigs, NV Harerimana, ...
The American Journal of Human Genetics 108 (3), 400-410, 2021
902021
A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer’s disease
Y Huang, X Sun, H Jiang, S Yu, C Robins, MJ Armstrong, R Li, Z Mei, ...
Nature communications 12 (1), 4472, 2021
462021
An integrated-omics analysis of the epigenetic landscape of gene expression in human blood cells
EM Kennedy, GN Goehring, MH Nichols, C Robins, D Mehta, T Klengel, ...
BMC genomics 19 (1), 476, 2018
442018
Brain DNA methylation patterns in CLDN5 associated with cognitive decline
A Hüls, C Robins, KN Conneely, R Edgar, PL De Jager, DA Bennett, ...
Biological psychiatry 91 (4), 389-398, 2022
372022
Association between DNA methylation levels in brain tissue and late-life depression in community-based participants
A Hüls, C Robins, KN Conneely, PL De Jager, DA Bennett, MP Epstein, ...
Translational psychiatry 10 (1), 262, 2020
322020
Testing evolutionary models of senescence: traditional approaches and future directions
C Robins, KN Conneely
Human genetics 133, 1451-1465, 2014
292014
Proteomic signatures improve risk prediction for common and rare diseases
J Carrasco-Zanini, M Pietzner, J Davitte, P Surendran, ...
Nature medicine 30 (9), 2489-2498, 2024
222024
Alnylam Human Genetics
BB Sun, J Chiou, M Traylor, C Benner, YH Hsu, TG Richardson, ...
AstraZeneca Genomics Initiative, Biogen Biobank Team, Bristol Myers Squibb …, 2023
222023
Testing two evolutionary theories of human aging with DNA methylation data
C Robins, AF McRae, JE Powell, HW Wiener, S Aslibekyan, EM Kennedy, ...
Genetics 207 (4), 1547-1560, 2017
132017
A genome-wide RNAi screen for microtubule bundle formation and lysosome motility regulation in drosophila S2 cells
AL Jolly, CH Luan, BE Dusel, SF Dunne, M Winding, VJ Dixit, C Robins, ...
Cell reports 14 (3), 611-620, 2016
102016
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.
C Cruchaga, M Ali, Y Shen, A Do, L Wang, D Western, M Liu, A Beric, ...
Research Square, 2024
62024
Proteomic prediction of common and rare diseases
J Carrasco-Zanini, M Pietzner, J Davitte, P Surendran, ...
medRxiv, 2023.07. 18.23292811, 2023
62023
Systematic disease-agnostic identification of therapeutically actionable targets using the genetics of human plasma proteins
MA Karim, B Ariano, J Schwartzentruber, JM Roldan-Romero, E Mountjoy, ...
medRxiv, 2023.06. 01.23290252, 2023
32023
Integrating human brain proteomes and genome‐wide association results implicates new genes in Alzheimer’s disease: Functionalizing genetic variants in Alzheimer’s disease
AP Wingo, Y Liu, J Gockley, BA Logsdon, D Duong, EB Dammer, ...
Alzheimer's & Dementia 16, e043865, 2020
22020
Identifying novel causal genes and proteins in Alzheimer’s disease: Genetics/genetic factors of Alzheimer's disease
C Robins, AP Wingo, J Meigs, D Duong, DJ Cutler, PL De Jager, JJ Lah, ...
Alzheimer's & Dementia 16, e043523, 2020
12020
Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease
M Ali, J Timsina, Y Shen, A Do, L Wang, D Western, E Liu, A Beric, G Heo, ...
Alzheimer's & Dementia 20 (Suppl 2), e084185, 2025
2025
Patient stratification by genetic risk in Alzheimer’s disease is only effective in the presence of phenotypic heterogeneity
J Euesden, M Ali, C Robins, P Surendran, P Gormley, ...
PloS one 20 (1), e0310977, 2025
2025
系统目前无法执行此操作,请稍后再试。
文章 1–20